Brazil's Patent Reform Pedro Paranaguá Advisor to the ruling Workers Party Brazilian House of PedroParanagua 3rd Global.

Slides:



Advertisements
Similar presentations
World Bank STI Capacity Building Programs: IP As A Crosscutting Issue Alfred Watkins S&T Program Coordinator Geneva November 6, 2009.
Advertisements

Synergies between IP governance and South –South Cooperation on IP and Development First WIPO Interregional Meeting on South-South Cooperation on IP Governance;
Brazil: from universal ARV access to universal HCV treatment? Juliana Vallini Friday, 23rd, July, 2010.
Actions Developing in Countries Accessing the WTO System Vung Tau, February 2006 “US – Brazil Compulsory licensing.
© 2011 Leonardos & Licks Latest Developments of the Brazilian Patent System Prepared for the 2011 Tongji Global Intellectual Property Forum Otto Licks.
Benjamin Blasco Anna Ferretti Sophie Venet BIO615 Fall 2009.
February, 2011 AARHUS UNIVERSITY Rector Lauritz B. Holm-Nielsen AARHUS UNIVERSITY Research and Higher Education in Denmark Rector Lauritz B. Holm-Nielsen.
XIX International AIDS Conference July 2012 Washington DC, USA The Brazilian experience: the campaign for access to lopinavir/ritonavir and efavirenz compulsory.
Patent Law Issues in Recent FTAs Joshua D. Sarnoff Washington College of Law American University Washington, DC, USA IP, FTAs,
MFJ International, LLC A Global Consulting Firm IP and FTAs: Significant Issues in Current Negotiations and their Relation to US IP Laws Workshop on IP,
I.1 ii.2 iii.3 iv.4 1+1=. i.1 ii.2 iii.3 iv.4 1+1=
I.1 ii.2 iii.3 iv.4 1+1=. i.1 ii.2 iii.3 iv.4 1+1=
Intellectual Property, Free Trade Agreements and sustainable Development Hanan Sboul Secretary General/ The Jordanian Association of Pharmaceutical Manufacturers.
The United States Constitution
Access to Innovation: Making Generic Versions of Newer Antiretrovirals Affordable Focusing on middle income countries Leena Menghaney, MSF Access Camapign.
Intellectual Property and Access to Affordable Medicines: TRIPS Plus
THE ROLE OF INTELLECTUAL PROPERTY RIGHTS IN PROTECTING TRADITIONAL KNOWLEDGE The Philippine Experience Presented by: Marga C. Domingo-Morales Senior Policy.
A very short introduction to patents & access to medicines.
Medicines & Related Substances Amendment Bill: Protecting the Nation’s Health “The State must take reasonable legislative and other measures, within its.
DOMESTICATION OF TRIPS FLEXIBILITIES IN NATIONAL IP LEGISLATION FOR STRENGTHENING ACCESS TO MEDICINES IN ZAMBIA AN OVERVIEW OF PATENT PROTECTION IN ZAMBIA.
TRIPS flexibilities and examples which resulted in reduced medicine prices: Model legislation and compulsory licensing in Brazil Juliana V. Borges Vallini.
TRIPS Flexibilities Preventive Measures Johanna von Braun, PhD University of Cape Town, South Africa Kiev, 21/22 nd June, 2010.
Congressional Committees. Standing committees Select committees Joint Committees Conference Committees.
Government Final Exam Review
IPRs serving innovation BioVision April Bibliotheca Alexandrina Ahmed Abdel Latif International Centre for Trade and Sustainable Development.
PATENTS AND HEALTH. A CASE STUDY OF THE UGANDAN CONTEXT. (PHA3 JULY 7 TH 2012 –CAPE TOWN, SOUTH AFRICA) MS. MARIAM AKIROR LLB (HONS) / DIP. SW / CPC. PROG.
Action against AIDS, Germany: Dr. Christiane Fischer MD PHD (presenter )(BUKO Pharma-Kampagne), Astrid Berner Rodoreda (Bread for the World) Igor Oliynyk.
Common themes TRIPS flexibilities – Assertion and erosion of flexibilities – Legal and regulatory reform – Use of flexibilities: opposition has generated.
DOMESTICATION OF TRIPS FLEXIBILITIES IN NATIONAL IP LEGISLATION FOR STRENGTHENING ACCESS TO MEDICINES IN ZAMBIA PROPOSED PATENT BILL AND ITS RELEVANCY.
NOIP: Challenges and Strategies IPRTA forum Mexico City, July 9-11, 2008 Pham Phi Anh Deputy Director General National Office of Intellectual Property.
Political Party Main Functions. (i) To contest elections: ● In most democracies, elections are fought mainly among the candidates put up by political.
The FTC, Pharmaceuticals, Antitrust & IP: A Grab Bag October 23, 2008 This presentation was prepared from public sources. The views expressed herein do.
What are the TRIPS flexibilities? How can their incorporation in patent legislation promote access to essential medicines? 25 November 2014, Maseru, Lesotho.
What are the TRIPS flexibilities? How will their incorporation in patent legislation promote access to essential medicines? IP and Access to Medicines:
UNCTAD/CD-TFT 1 Intellectual Property Rights and National Development Goals – Ensuring Innovation in Russia St. Petersburg/Moscow Study Tour 2008 Christoph.
Ten Years of the Doha Declaration: The State of Implementation Geneva 14 November
MFJ International, LLC A Global Consulting Firm “FTAs and Pharmaceuticals: a hijacked process?” M. Fabiana Jorge CPTECH November 16, 2006.
UNCTAD/CD-TFT 1 Exclusive Rights and Public Access – Flexibilities in International Agreements and Development Objectives The Public Health Example 21.
Intellectual Property Rights and Pharmaceuticals (Case study- Novartis’s claim in India) Background note prepared for PHM Vic Internet Workshop.
Review of the Activities by the Korea Fund in Trust Seong Joon PARK Permanent Mission of the Rep. of Korea Nov. 5, 2009.
DOMESTICATION OF TRIPS FLEXIBILITIES IN NATIONAL IP LEGISLATION FOR STRENGTHENING ACCESS TO MEDICINES IN ZAMBIA PROPOSED PATENT BILL AND ITS RELEVANCY.
Denise Gregory South-South and Triangular Cooperation Partnerships for Innovation Support Interregional Expert Meeting South-South and Triangular Cooperation.
Civil Society Strategy Meeting on the Future of Access to Medicines Bangkok, December 2011 Intellectual Property/Trade and Access to Medicines Session.
Structure of the U.S. Constitution. *Preamble: sets out the purpose and goals of the Constitution (6 purposes listed) form a more perfect union establish.
Implementation of TRIPS Flexibilities In National IP Legislation For Strengthening Access To Medicines In Swaziland Workshop with MOH and stakeholders,
Intellectual Property rights (IPR)
INTELLECTUAL PROPERTY AND THE COMPETITIVENESS OF SMALL AND MEDIUM-SIZED ENTERPRISES IN THE TEXTILE INDUSTRY IN CHINA CAO Jinyan, Deputy Director General.
Selected Contemporary Issues in Field of Patents WIPO-UKRAINE SUMMER SCHOOL ON INTELLECTUAL PROPERTY – JULY 2011.
Standing Committee on the Law of Patents Standing Committee on the Law of Patents Created in 1998, it ‘serves as a forum to discuss issues, facilitate.
Government Review. Constitution Review  How does the Constitution limit government and protect the rights of the individual?  -Bill of Rights: limits.
Bangkok A Strong Generic Competition for a Sustainable Agriculture and an Innovative Dominant Industry.
1 Teaching Innovation - Entrepreneurial - Global The Centre for Technology enabled Teaching & Learning, N Y S S, India DTEL DTEL (Department for Technology.
The Third Revision of the Chinese Patent Law State Intellectual Property Office of P.R.C Dec
 Constitution – body of fundamental laws which say how a government is to operate  It is the supreme law of the land  It explains how the government.
NAFTA, CAFTA and Access to Medicines and Food Security in Latin America International Aids Conference Session “Globalization and FTAs: their impact, access.
Intellectual Property, Free Trade Agreements and sustainable Development Hanan Sboul Secretary General/ The Jordanian Association of Pharmaceutical Manufacturers.
Intellectual Property and Access to Affordable Medicines: TRIPS Plus
Patent Office Responsibilities in Technology Transfer
Intellectual Property Protection and Access to Medicines
Making medicines, diagnostics and other commodities more affordable
Norunnuha Sdn Bhd Patent Trademark Design
Role of IP in facilitating the transfer of technology
Sec. 1 Sec. 2 Sec. 3 Sec. 4 Sec. 5 Sec. 6 Sec. 7 Sec. 8 Sec. 9 Sec. 10
Structure of the united states government
IP Provisions in Bilateral & Regional Trade Agreements and Public Health ICTSD/QUNO Dinner Discussion on IPRs in Bilateral & Regional Trade Agreements.
Treat the world: Working united across diseases for quality and affordable treatment for all – AIDS 2018 TRIPS Flexibilities 0.2 Across Diseases Ellen.
IP Protection in China: Trends and Challenges
Green Finance and the Transformation of Property in Brazil: Building New Theoretical and Empirical Knowledge.
Federal legislative action: hope and challenges
Presentation transcript:

Brazil's Patent Reform Pedro Paranaguá Advisor to the ruling Workers Party Brazilian House of PedroParanagua 3rd Global Congress on IP & Public Interest University of Cape Town, 12 December 2013

I. why II. how III. findings IV. what V. individuals VI. future Brazil's Patent Reform

I. why Brazil's Patent Reform

– disparity – high production of knowledge – low # of patents Brazil's Patent Reform Rep. Newton Lima

II. how Brazil's Patent Reform

● 7 public hearings: House of Rep., PTO, Univ. of São Paulo, Univ. Campinas ● 30+ experts: gov., industry, academia, civil society ● extensive research: legislation (Argentina, China, India), gov. & intl. org. reports (UK, US, WHO, WIPO) Brazil's Patent Reform

link

III. findings Brazil's Patent Reform

● Brazil hastily approved its patent bill in 1996 ● did not implement TRIPs flexibilities ● prejudicial consequences to innovation + extraordinary increase of prices Brazil's Patent Reform

closed 1,096 plants (Min. of Trade & Industry) no development of local production >> USD $10 billion deficit (Min. of Health) ● 70% decrease of TT (Fiocruz) revalidation patents (pipeline) >> losses of USD $529 million related to 5 ARVs (Federal Univ. Rio/Economics) Brazil's Patent Reform

IV. what Brazil's Patent Reform

● 1. Patent Reform Bill H.R. 5402/2013 ● 2. Council on IPRs ● 3. Recommendations Brazil's Patent Reform

● a) limit patent term to 20 years ● b) pre-grant opposition ● c) prohibit new forms of known substances + second uses Brazil's Patent Reform

● d) augment the level of the inventive step requirement (to promote follow-on innovation) ● e) undisclosed test data: protected by unfair competition >> rather than data exclusivity ● f) public non-commercial use Brazil's Patent Reform

● g) Anvisa's prior consent ● i) health risks >> based on previously rejected products ● ii) pharma or chemical products of interest to the National Health System (SUS) and that do not comply with the patentability requirements Brazil's Patent Reform

V. individuals Brazil's Patent Reform

you

VI. future Brazil's Patent Reform

● too many variables Brazil's Patent Reform

● new Ministers of Health + Trade & Industry 2014 national presidential election ● Patent Office ● national + intl. industry + TPP... ● civil society Brazil's Patent Reform

Dankie ! Thank you! Pedro Paranaguá Advisor to the ruling Workers Party Brazilian House of Representatives LL.M. (London), Doctorate Candidate PedroParanagua